Literature DB >> 11427244

Consultation-Liaison psychiatric service delivery: results from a European study.

F J Huyse1, T Herzog, A Lobo, U F Malt, B C Opmeer, B Stein, P de Jonge, R van Dijck, F Creed, M D Crespo, G Cardoso, R Guimaraes-Lopes, R Mayou, M van Moffaert, M Rigatelli, P Sakkas, P Tienari.   

Abstract

The reported findings of the European Consultation-Liaison Workgroup (ECLW) Collaborative Study describe consultation-liaison service delivery by 56 services from 11 European countries aggregated on a C-L service level. During the period of 1 year (1991), the participants applied a standardized, reliability tested method of patient data collection, and data were collected describing pertinent characteristics of the hospital, the C-L service, and the participating consultants. The consultation rate of 1% (median; 1.4% mean) underscores the discrepancy between epidemiology and the services delivered. The core function of C-L services in general hospitals is a quick, comprehensive emergency psychiatric function. Reasons to see patients were the following. deliberate self-harm (17%), substance abuse (7.2%), current psychiatric symptoms (38.6%), and unexplained physical complaints (18.6%) (all means). A significant number of patients are old and seriously ill. Mood disorders and organic mental disorders are most predominant (17.7%). Somatoform and dissociative disorders together constitute 7.5%. C-L services in European countries are mainly emergency psychiatric services and perform an important bridge function between primary, general health, and mental health care.

Entities:  

Mesh:

Year:  2001        PMID: 11427244     DOI: 10.1016/s0163-8343(01)00139-6

Source DB:  PubMed          Journal:  Gen Hosp Psychiatry        ISSN: 0163-8343            Impact factor:   3.238


  27 in total

1.  Consultation-liaison psychiatry worldwide.

Authors:  Francis Creed
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

2.  The future of consultation-liaison psychiatry: prosper or perish?

Authors:  Ulrik F Malt
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

3.  From consultation to integrated health risk assessment.

Authors:  Frits J Huyse
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

4.  Adjustment disorders: the state of the art.

Authors:  Patricia Casey; Susan Bailey
Journal:  World Psychiatry       Date:  2011-02       Impact factor: 49.548

Review 5.  [Bio-psycho-socio or psychotherapeutic medicine - actual development of psychosomatics in clinical practice].

Authors:  Hans-Christian Deter
Journal:  Wien Med Wochenschr       Date:  2017-07-25

6.  Implementing Motivational Interviewing for Substance Misuse on Medical Inpatient Units: a Randomized Controlled Trial.

Authors:  Steve Martino; Paula Zimbrean; Ariadna Forray; Joy S Kaufman; Paul H Desan; Todd A Olmstead; Kathryn Gilstad-Hayden; Ralitza Gueorguieva; Kimberly A Yonkers
Journal:  J Gen Intern Med       Date:  2019-08-29       Impact factor: 5.128

7.  Consultation-Liaison Psychiatry in the General Hospital: the Experience of UK, Italy, and Japan.

Authors:  Luigi Grassi; Alex J Mitchell; Makoto Otani; Rosangela Caruso; Maria Giulia Nanni; Maki Hachizuka; Kaori Takahashi; Saori Yamamoto; Tsuyoshi Akiyama; Michelle Riba
Journal:  Curr Psychiatry Rep       Date:  2015-06       Impact factor: 5.285

Review 8.  Adjustment disorder: epidemiology, diagnosis and treatment.

Authors:  Patricia Casey
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

9.  Pattern of psychiatric referrals in a tertiary care teaching hospital in southern India.

Authors:  Narayana Keertish; M T Sathyanarayana; B G Hemanth Kumar; Nitesh Singh; Kaveri Udagave
Journal:  J Clin Diagn Res       Date:  2013-08-01

10.  The psychosocial evaluation of medically-ill inpatients - accordance between mental disorders and self-rated psychosocial distress.

Authors:  Kurt Fritzsche; Thorsten Burger; Armin Hartmann; Matthias Nübling; Claudia Spahn
Journal:  Psychosoc Med       Date:  2005-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.